Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Daniel, Peter Prof. Dr. (1) Kammertöns, Thomas Dr. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (5) Pezzutto, Antonio Prof. Dr. (1) Scheidereit, Claus Prof. Dr. (1) Selbach, Matthias Prof. Dr. (4) Uckert, Wolfgang Prof. Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (3) (-) Janz, Martin Dr. (5) (-) Leisegang, Matthias Prof. Dr. rer. nat. (1) (-) Wollert-Wulf, Brigitte (2) 1992 (4) 1993 (7) 1994 (5) 1996 (6) 1997 (9) 1998 (9) (-) 1999 (3) 2000 (9) 2001 (5) 2002 (6) 2003 (12) 2004 (10) 2005 (12) (-) 2006 (5) 2007 (7) 2008 (7) 2009 (5) 2011 (9) 2013 (13) 2014 (5) 2015 (5) 2016 (5) 2017 (9) 2018 (5) 2019 (6) 2020 (5) 2021 (7) 2022 (10) 2023 (10) 2024 (3) (-) Biology of Malignant Lymphomas (5) Genetics and Genomics of Cardiovascular Diseases (1) (-) Molecular Immunology and Gene Therapy (3) 8 Results: Active Filter: Blankenstein, Thomas Prof. Dr.Janz, Martin Dr.Leisegang, Matthias Prof. Dr. rer. nat.Wollert-Wulf, BrigitteBiology of Malignant LymphomasMolecular Immunology and Gene Therapy19992006 Sort: Result score Newest to oldest Oldest to newest January 01, 1999 / Eur J Immunol Direct and indirect T cell priming by dendritic cell vaccines S. Cayeux G. Richter C. Becker A. Pezzutto B. Doerken T. Blankenstein March 01, 1999 / J Exp Med T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice T. Schueler Z. Qin S. Ibe N. Noben-Trauth T. Blankenstein January 01, 1999 / Onkologe Regulation des Zellzyklus und therapeutische Implikationen H.D. Royer E. Grinstein M. Janz November 01, 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken May 15, 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
January 01, 1999 / Eur J Immunol Direct and indirect T cell priming by dendritic cell vaccines S. Cayeux G. Richter C. Becker A. Pezzutto B. Doerken T. Blankenstein
March 01, 1999 / J Exp Med T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice T. Schueler Z. Qin S. Ibe N. Noben-Trauth T. Blankenstein
January 01, 1999 / Onkologe Regulation des Zellzyklus und therapeutische Implikationen H.D. Royer E. Grinstein M. Janz
November 01, 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
May 15, 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou